Point72 Asia (Singapore) Pte. Ltd. Ocugen, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Ocugen, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 115,773 shares of OCGN stock, worth $137,769. This represents 0.03% of its overall portfolio holdings.
Number of Shares
115,773
Previous 231,542
50.0%
Holding current value
$137,769
Previous $225 Million
16.01%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding OCGN
# of Institutions
107Shares Held
61.4MCall Options Held
531KPut Options Held
433K-
Black Rock Inc. New York, NY17.9MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$18.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.16MShares$4.95 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.94 Million0.31% of portfolio
-
Geode Capital Management, LLC Boston, MA3.68MShares$4.38 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $258M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...